Ikarian Capital »

Nurix Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.2M 441k 20.87
2024-03-31 $4.4M 300k 14.70

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Deep Track Capital
Baker Bros. Advisors
Vanguard Group
T. Rowe Price Associates
State Street Corporation
ARK Investment Management
T. Rowe Price Investment Management
Soleus Capital Management
Morgan Stanley
Geode Capital Management
Driehaus Capital Management
Candriam Luxembourg S.C.A.
Citadel Advisors

View all funds holding Nurix Therapeutics